Inicio>>Signaling Pathways>> GPCR/G protein>> Angiotensin Receptor>>Pratosartan (FW 7203)

Pratosartan (FW 7203) (Synonyms: FW 7203; KD 3-671; KT 3671)

Catalog No.GC32530

Pratosartan (FW 7203) es un antagonista selectivo del receptor de angiotensina II.

Products are for research use only. Not for human use. We do not sell to patients.

Pratosartan (FW 7203) Chemical Structure

Cas No.: 153804-05-8

Tamaño Precio Disponibilidad Cantidad
1mg
534,00 $
Disponible
5mg
1.057,00 $
Disponible
10mg
1.801,00 $
Disponible
20mg
3.171,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Pratosartan is a selective angiotensin II receptor antagonist.

Pratosartan, which is an orally active angiotensin II (AII) antagonist, exhibiting selective and potent antagonistic activity to AT1 subtype[1]. Pratosartan is a new angiotensin II type 1 receptor blocker. Pratosartan is an effective and well tolerated antihypertensive drug, and may has beneficial effect on hypertensive patients with some metabolic disorders[2].

[1]. Sonegawa M, et al. Synthesis and pharmacological activity of the metabolites of Pratosartan. Chem Pharm Bull (Tokyo). 2006 Jun;54(6):782-7. [2]. Ogihara T, et al. Clinical efficacy of a new angiotensin II type 1 receptor blocker, pratosartan, in hypertensive patients. Hypertens Res. 2008 Feb;31(2):281-7.

Reseñas

Review for Pratosartan (FW 7203)

Average Rating: 5 ★★★★★ (Based on Reviews and 29 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Pratosartan (FW 7203)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.